WESAIL's COVID-19 diagnostic family includes Antigen Test Kits, Neutralizing Antibody Test Kits, Flu+Ag Test Kits and IgM/IgG Test Kits, which has completed registration and established strong sales in Germany, Italy, Spain, Russia, Turkey and other countries.
Find Out More

Medical Wire (MWE) has upscaled production of its inactivation medium Sigma MM™ that inactivates bacteria and viruses & preserves RNA/DNA for molecular testing. Public Health England has confirmed it inactivates SARS-CoV-2 within 1-hour. 
Find Out More

Bioperfectus aims to supply the world with its clinically proven & UK government evaluated accurate rapid antigen test for COVID-19. In this feature, find why there's a shortage of antigen tests on the market and how Bioperfectus can help. 
Find Out More

Prognosis Biotech's patient-friendly nasal swab rapid antigen test is suitable for sensitive individual groups due to its non-invasive procedure. The test demonstrated superior diagnostic accuracy in an independent clinical trial carried out in Greece's COVID-19 reference lab.
Find Out More

Overcome problems of low recovery, high bacterial content, sheared DNA, and excessive resampling costs, the iSWAB™ collection device allows the release of cells captured from any swab into a proprietary lysis and stabilizing buffer.
Find Out More

Mid-turbinate swab has notch markings on the nylon shaft to make getting the required depth easier for pediatric patients, whilst the face of a bear, helps distract and put younger patients at ease.
Find Out More

BATM Advanced Communications Ltd. has launched a new self-collected saliva-based RT-PCR test that significantly improves the sample collection process and turnaround times while maintaining diagnostic accuracy.
Find Out More

The US FDA is alerting clinical laboratory staff, point-of-care (POC) facility staff, and health care providers that false-positive results can occur with the Roche Molecular Systems, Inc. (Roche) cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test for use on the cobas Liat System.
Find Out More

Oxford Immunotec has submitted an Emergency Use Authorization Request to the FDA for its CE-marked T-SPOT®.COVID, a test for detecting a cell-mediated (T cell) Immune Response to SARS-CoV-2 Infection.
Find Out More

Intrivo is offering its lateral-flow CareStart™ rapid antigen test through Amazon Business. A recent amendment to the test's EUA allows for lower nasal swabs to collect viral protein samples without affecting the test's sensitivity and specificity. 
Find Out More